CMBA
PAHC icon

C.M. Bidwell & Associates’s Phibro Animal Health PAHC Stock Holding History

C.M. Bidwell & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,639
Closed -$90.7K – 532
2026
Q1 		$90.7K Sell
1,639
-496
-23% -$23.6K 0.04% 184
2025
Q4 		$79.8K Buy
2,135
+2,020
+1,757% +$82K 0.04% 202
2025
Q3 		$4.65K Buy
+115
New +$3.8K ﹤0.01% 338

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

C.M. Bidwell & Associates's PAHC Position: Q2 2026 in Review

C.M. Bidwell & Associates sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 1,639 shares — an estimated $90.7K sold.

C.M. Bidwell & Associates first reported a position in PAHC in Q3 2025 and held it in 3 quarters. The position peaked at $90.7K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • C.M. Bidwell & Associates reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,639 Phibro Animal Health shares in Q2 2026, an estimated $90.7K.
  • C.M. Bidwell & Associates first reported a position in Phibro Animal Health in Q3 2025 and held it in 3 quarters.
  • C.M. Bidwell & Associates's Phibro Animal Health position peaked at $90.7K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.